Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Caffeine metabolism in the newborn.

Aldridge A, Aranda JV, Neims AH.

Clin Pharmacol Ther. 1979 Apr;25(4):447-53.

PMID:
428190
2.

[HPLC determination of five caffeine metabolites].

Lu JF, Yi T, Cao XM, Zhuo HT, Lin SS.

Yao Xue Xue Bao. 1997 Aug;32(8):607-11. Chinese.

PMID:
11596311
3.
4.

Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.

Cazeneuve C, Pons G, Rey E, Treluyer JM, Cresteil T, Thiroux G, D'Athis P, Olive G.

Br J Clin Pharmacol. 1994 May;37(5):405-12.

5.

Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration.

Callahan MM, Robertson RS, Arnaud MJ, Branfman AR, McComish MF, Yesair DW.

Drug Metab Dispos. 1982 Jul-Aug;10(4):417-23.

PMID:
6126344
7.

Urinary excretion of an uracilic metabolite from caffeine by rat, monkey and man.

Latini R, Bonati M, Marzi E, Garattini S.

Toxicol Lett. 1981 Jan;7(3):267-72.

PMID:
7222102
8.

Pharmacokinetic aspects of caffeine in premature infants.

De Carolis MP, Romagnoli C, Muzii U, Tortorolo G, Chiarotti M, De Giovanni N, Carnevale A.

Dev Pharmacol Ther. 1991;16(3):117-22.

PMID:
1914785
9.

Urinary metabolites of caffeine in young dogs.

Warszawski D, Ben-Zvi Z, Gorodischer R, Arnaud MJ, Bracco I.

Drug Metab Dispos. 1982 Jul-Aug;10(4):424-8.

PMID:
6126345
10.

The fate of chronically consumed caffeine in the monkey (Macaca fascicularis).

Gilbert SG, Stavric B, Klassen RD, Rice DC.

Fundam Appl Toxicol. 1985 Jun;5(3):578-87.

PMID:
4007312
12.

An automated HPLC assay for simultaneous quantitation of methylated xanthines and uric acids in urine.

Tang-Liu DD, Riegelman S.

J Chromatogr Sci. 1982 Apr;20(4):155-9.

PMID:
7096523
13.

Effect of growth hormone on caffeine metabolism in hypophysectomized rats.

Bienvenu T, Pons G, Rey E, Richard MO, d'Athis P, Arnaud MJ, Olive G.

Drug Metab Dispos. 1990 May-Jun;18(3):327-30.

PMID:
1974194
14.

Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.

Vincent-Viry M, Pontes ZB, Gueguen R, Galteau MM, Siest G.

Genet Epidemiol. 1994;11(2):115-29.

PMID:
8013893
15.

Caffeine clearance and biotransformation in patients with chronic liver disease.

Scott NR, Stambuk D, Chakraborty J, Marks V, Morgan MY.

Clin Sci (Lond). 1988 Apr;74(4):377-84.

PMID:
3356110
16.

HPLC method for rapid determination of acetylator phenotype by measuring urinary caffeine metabolites.

Klebovich I, Arvela P, Pelkonen O.

J Pharm Biomed Anal. 1993 Oct;11(10):1017-21.

PMID:
8305582
17.

A urinary metabolite ratio that reflects systemic caffeine clearance.

Campbell ME, Spielberg SP, Kalow W.

Clin Pharmacol Ther. 1987 Aug;42(2):157-65.

PMID:
3608349
18.

Developmental aspects of theophylline metabolism in premature infants.

Tserng KY, Takieddine FN, King KC.

Clin Pharmacol Ther. 1983 Apr;33(4):522-8.

PMID:
6831832
19.

Elimination of chronically consumed caffeine in the pregnant monkey (Macaca fascicularis).

Gilbert SG, So Y, Klassen RD, Geoffroy S, Stavric B, Rice DC.

J Pharmacol Exp Ther. 1986 Dec;239(3):891-7.

PMID:
3795047
20.

[Peculiarities of the pharmacokinetics and pharmacodynamics of theophylline in children].

Berdel D, Heimann G.

Wien Klin Wochenschr. 1984 Aug 31;96(16):616-21. German.

PMID:
6516414

Supplemental Content

Support Center